Gammaitoni Arnold

Gammaitoni Arnold has a diverse work experience spanning over several companies and roles. Gammaitoni started their career in 1995 as a co-founder and Vice President at excelleRx, where they played a crucial role in developing medication use guidelines for managing end-of-life symptoms. Gammaitoni then joined Endo Pharmaceuticals in 2001 as a Senior Director in Medical Affairs, where they built a successful medical affairs organization and led various research projects. In 2006, Gammaitoni joined Merck as the Global Director of Scientific Affairs, where they were responsible for developing a scientific leader engagement strategy in the areas of arthritis, analgesia, and anesthesia. Gammaitoni later joined Nuvo Research Inc. in 2011 as the VP of Scientific Affairs, where they developed and implemented a scientific leadership engagement strategy. Gammaitoni then moved to Zogenix in 2013 as the SVP of Global Medical and Scientific Affairs, where they worked with various departments to establish and implement an annual scientific leadership engagement strategy. Currently, they are working at Rapport Therapeutics as the SVP of Medical Affairs.

Gammaitoni Arnold obtained a Postgraduate Certificate in Pain Management from the University of California, San Francisco, during the years 2006 to 2007. Prior to this, from 1995 to 2002, Arnold pursued a Pharm.D. degree in Pain from the University of the Sciences in Philadelphia.